EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports Second Quarter 2024 Financial Results
August 28, 2024 07:00 ET | EDAP TMS S.A.
        Record Q2 2024 total worldwide revenue of EUR 15.8 million (USD 17.0 million) increased 10.6% over Q2 2023Record first half 2024 total worldwide revenue of EUR 30.7 million (USD...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
August 07, 2024 07:00 ET | EDAP TMS S.A.
Company to host conference call and webcast on Wednesday, August 28th at 8:30am EDT LYON, France, August 7, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
August 06, 2024 07:00 ET | EDAP TMS S.A.
Semi-Live Focal One Procedure to be Conducted on August 15th at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
July 19, 2024 16:15 ET | EDAP TMS S.A.
        Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in patients with deep infiltrating endometriosisAt...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Appoints Fran Schulz to Board of Directors  
July 08, 2024 07:00 ET | EDAP TMS S.A.
PDF Version LYON, France, July 8, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Fran Schulz to...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
June 03, 2024 08:00 ET | EDAP TMS S.A.
New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing disruptive, robotics-based capital equipment in both...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Present at the Jefferies Global Healthcare Conference
May 22, 2024 08:00 ET | EDAP TMS S.A.
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports First Quarter 2024 Financial Results
May 16, 2024 08:00 ET | EDAP TMS S.A.
         Strong Q1 2024 U.S. Focal One® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023Q1 2024 total revenue...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
May 06, 2024 08:00 ET | EDAP TMS S.A.
         Final results demonstrate a significantly higher salvage treatment free survival rate (STFS) at 30 months of 89.6% in the HIFU-treated arm versus 86.2% in patients who...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
May 02, 2024 08:00 ET | EDAP TMS S.A.
Company to host conference call and webcast on Thursday, May 16th at 8:30am EDT LYON, France, May 2, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based...